InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Pacira BioSciences, Inc.

PCRX Clue Score50
United States Fiscal year ends December CIK 0001396814 Results filed 4 Aug 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Lauren Riker
8 Oct 2026
Senior Vice President, Finance
Sold after exercise
6,000
$36.32
$217.92K
Shawn Cross
23 Apr 2026
Chief Financial Officer
Sold after exercise
12,941
$25.16
$325.60K
Shawn Cross
22 Apr 2026
Chief Financial Officer
Sold after exercise
1,500
$25.01
$37.52K
Shawn Cross
21 Apr 2026
Chief Financial Officer
Sold after exercise
2,845
$25.01
$71.15K
Shawn Cross
20 Apr 2026
Chief Financial Officer
Sold after exercise
7,714
$25.14
$193.93K
Shawn Cross
10 Dec 2025
Chief Financial Officer
Sold after exercise
9,104
$25.14
$228.87K
Shawn Cross
9 Dec 2025
Chief Financial Officer
Sold after exercise
15,896
$25.03
$397.88K
Show all 17 transactions →

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 9
Sales straight out of an exercise 7
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 700,743
History held since 10 Feb 2011